Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Cerulean Pharma Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

27 Jun 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Cerulean Pharma Inc (CERU-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

29 Jun 2015 Thomson Reuters Stock Report 11 $25.00

US MARKET ANALYSIS AND FORECAST. 70 PAGE REPORT PUBLISH QUARTERLY. IN EACH REPORT YOU WILL FIND 12-MONTHS FORECASTS ANALYSIS TARGET PRICE VALUATION RATINGS AND CREUDE OIL DEPENDENCE FOR 7396 US STOCKS.

29 Jun 2015 Pechala's Reports 83 $1,000.00

Wright Investors Service Comprehensive Report for Cerulean Pharma Inc

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

25 Jun 2015 Wright Reports 50 $75.00

ValuEngine Industry Report for Medical-drugs(CERU)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

25 Jun 2015 ValuEngine, Inc. 10 $49.00

ValuEngine Rating and Forecast Report for CERU

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

18 May 2015 ValuEngine, Inc. 10 $25.00

CERULEAN - ENTERING A NEWSFLOW-RICH PERIOD

Cerulean looks well positioned to progress its ripening pipeline after a recent successful share offer and the receipt of FDA...

11 May 2015 Edison Investment Research 2 $10.00

CERU.OQ - Event Transcript of Cerulean Pharma Inc conference call, May 06, 2015 / 4:30PM ET

Edited Event Transcript of CERU.OQ conference call, May 06, 2015 / 4:30PM ET Boston, May 13, 2015 (Thomson StreetEvents...

06 May 2015 Thomson Reuters StreetEvents 10 $75.00

Cerulean Pharma, Inc. (CERU) - Financial Analysis Review

Cerulean Pharma, Inc. (CERU) - Financial Analysis Review Summary Cerulean Pharma, Inc. (Cerulean) is a biopharmaceutica...

05 May 2015 GlobalData 41 $125.00

CERULEAN - POSITIVE DATA ANNOUNCED FOR CRLX101 IN RCC

In conjunction with its FY14 results, Cerulean announced strong top-line interim data for CRLX101 in its lead indication of r...

20 Mar 2015 Edison Investment Research 2 $10.00